Partial Thromboplastin Time
PTT
Description
Parathyroid Hormone (PTH) test measures the amount of PTH in your blood, helping your doctor assess how effectively your body regulates calcium levels. It’s often used to evaluate overactive or underactive parathyroid glands or investigate calcium imbalances. During the test, a blood sample is taken to measure PTH levels. High levels might indicate overactive parathyroid glands or calcium buildup in the blood, while low levels could point to underactivity or a vitamin D deficiency. This test is especially helpful if you’re experiencing fatigue, bone pain, or abnormal calcium levels. Your doctor will use the results to guide next steps, like adjusting your diet, prescribing medication, or ordering additional tests. Regular PTH testing supports calcium and bone health over time.
Procedure
Invasive
Sample Type
Blood – Serum
Test Category
Clotting Factors
Procedure Category
Blood Draw
Units
Seconds
Test Groups
Coagulation Group: These targeted tests are designed to assess clotting factors and coagulation pathways, offering valuable insights into hemostasis and thrombotic disorders. Complete Liver Group: A thorough array of tests aimed at assessing liver function, providing detailed insights into hepatic health and related conditions. Gallbladder Group: This group of tests evaluates gallbladder function and health, providing insights into digestive well-being and related conditions.
Optimal Range
For All Individuals:
Conventional Unit: 27.00–32.00 sec
SI Unit: Not Applicable
Normal Range
For All Individuals:
Conventional Unit: 25.00–35.00 sec
SI Unit: Not Applicable
Results That Differ From The Norm (Direct and Indirect Causes)
Increased levels may indicate:
Amyloidosis (Abnormal protein buildup leading to tissue damage)
Antiphospholipid syndrome (Autoimmune disorder causing blood clots)
Cirrhosis (Liver scarring impairing liver function)
Disseminated intravascular coagulation (Widespread clotting in small blood vessels)
Hemophilia (Genetic disorder impairing blood clotting)...
Key Reasons For Testing
Coagulation Assessment: Evaluates the intrinsic and common pathways of the coagulation cascade to measure clotting time.
Monitoring Anticoagulant Therapy: Assesses the effectiveness of unfractionated heparin therapy to guide dosing adjustments.
Diagnosis of Bleeding Disorders: Screens for conditions like hemophilia A and B, von Willebrand disease, and factor deficiencies.
Assessment of DIC: Identifies and monitors disseminated intravascular coagulation, a critical clotting and bleeding disorder.
Health Status Conditions It May Be Used To Assess
Currently, this test is not directly associated with any conditions listed on the Health Status page. However, it may be included as part of a broader set of tests linked to specific health conditions.
Some Prominent Medical Labs That May Offer This Test
Please note that this particular test has not been associated with any of the listed prominent medical labs. We recommend enquiring with your private physician or nearest hospital to determine where this specific test can be performed.
References
Important Note
Any medical procedure yielding results outside the norm may be directly or indirectly linked to the conditions outlined on this page. Various factors, including genetics, medication and supplement usage, recent illnesses, pregnancy, pre-test eating, smoking, and stress, can impact the test's outcome. Additionally, factors like false positives, false negatives, inaccurate analyses, and others can influence results.
Reference ranges, which help healthcare professionals interpret medical tests, may vary depending on age, gender, and other factors. They may also differ between laboratories due to variations in instruments and methods used. Optimal ranges are designed for preventive purposes, aiming to identify trends and potential risks early, while normal ranges reflect conventional laboratory values indicating no current disease or pathology. Your healthcare practitioner may have specific reasons for testing that deviate from the usual or may interpret results differently based on individual circumstances. Proper interpretation typically involves considering clinical findings and other diagnostic tests. Hence, it is crucial to provide your healthcare professionals with a comprehensive medical history, consult with them for result interpretation, and follow their guidance for potential re-testing or additional diagnostics.
Disclaimer
This content is provided solely for informative and educational purposes. It is not intended as a substitute for medical advice or treatment from a personal physician. Regarding the interpretation of their medical test results and/or specific health questions, it is recommended that all readers and viewers consult their physicians or other qualified health professionals. The publisher is not responsible for any adverse health effects that may result from reading or following the information in this educational content. Before beginning any nutrition, supplement, or lifestyle program, all viewers, especially those taking prescription or over-the-counter medications, should consult their physician or health care practitioner.
Please note that while prominent lab names are included in this content, we cannot guarantee that these labs offer all the tests mentioned. For confirmation, individuals should contact the labs directly or consult their medical practitioners. The information provided reflects general knowledge at the time of publication and may not include recent updates or emerging research. Readers should verify details with qualified professionals to ensure the most up-to-date and accurate guidance.
[1] Bauer KA. Laboratory markers of coagulation and fibrinolysis. In: Hoffman R, Benz EJ, Silberstein LE, et al, eds. Hematology: Basic Principles and Practice. 7th ed. Philadelphia, PA: Elsevier; 2018.173.
[2] Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med. 2011;365(2):147-156.
[3] Brummel-Ziedins KE, Wolberg AS, Mann KG. Assessing the role of thrombin generation in the regulation of hemostasis. Semin Thromb Hemost. 2005;31(1):80-89.
[4] Huisman MV, Büller HR, ten Cate JW. Activated partial thromboplastin time and bleeding risk in anticoagulant therapy. Thromb Haemost. 1987;58(1):54-58.
[5] Dzieciol N, Muraszko-Klaudia J, Czyzewska-Pietras K, et al. Monitoring of anticoagulant therapy: an update on partial thromboplastin time tests. Adv Clin Exp Med. 2021;30(2):221-229.
[6] Kitchens CS, Kessler CM, Konkle BA. Consultative Hemostasis and Thrombosis. 4th ed. Philadelphia, PA: Elsevier; 2019.9.
[7] Burnett AE, Mahan CE, Vazquez SR, et al. Guidance for the practical management of the direct oral anticoagulants (DOACs) in VTE treatment. J Thromb Thrombolysis. 2016;41(1):206-232.
[8] Buller HR, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(3_suppl):401S-428S.
[9] Jennings I, Kitchen DP, Makris M, et al. Laboratory monitoring of anticoagulant therapy: monitoring oral anticoagulants. Clin Lab Haematol. 2005;27(5):297-302.
[10] Rosendaal FR, Cannegieter SC, van der Meer FJ, Briet E. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost. 1993;69(3):236-239.
[11] Choudhry NK, Anderson GM, Laupacis A. Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis. BMJ. 2006;332(7537):141-145.